GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
2,758.10
-2.60 (-0.09%)
Oct 24, 2025, 3:30 PM IST
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 465.91 billion as of October 24, 2025. Its market cap has increased by 5.29% in one year.
Market Cap
465.91B
Enterprise Value
441.03B
Revenue
37.40B
Ranking
n/a
PE Ratio
49.03
Stock Price
2,758.10
Market Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 465.91B, an increase of 2,334.21%. That is a compound annual growth rate of 14.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 465.91B | 22.12% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | 274.98B | 0.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.74T |
| Cipla | 1.28T |
| Apollo Hospitals Enterprise | 1.15T |
| Zydus Lifesciences | 1.01T |
| Mankind Pharma | 1.00T |
| Fortis Healthcare | 792.29B |
| Alkem Laboratories | 661.67B |